Key result
Stethoscope-recorded single-lead AI-ECG detects LVEF ≤40% with ~0.85 AUROC at the pulmonary valve.
Why the study?
Most patients with HFrEF (LVEF 40% or lower) are diagnosed in hospital despite previous primary care presentations with symptoms, motivating validation of a point-of-care AI algorithm applied to single-lead ECGs recorded during ECG-enabled stethoscope examination.
Can an artificial intelligence algorithm applied to single-lead ECGs recorded during a routine ECG-enabled stethoscope examination accurately detect reduced left ventricular ejection fraction (LVEF ≤40%) in adults attending for echocardiography?
Observational (n=1,050)
Members of the research team were unaware of participants' LVEF at the time of recording and remained blinded to these results for the duration of the study
Yes
Can an artificial intelligence algorithm applied to single-lead ECGs recorded during a routine ECG-enabled stethoscope examination accurately detect reduced left ventricular ejection fraction (LVEF ≤40%) in adults attending for echocardiography?
An AI algorithm applied to 15-second single-lead ECGs recorded during a standard stethoscope examination can reliably screen for LVEF ≤40% at the point of care (AUROC 0.85-0.91) across an ethnically diverse population.
Answers are grounded in this paper and cite their sources.
May support point-of-care LVEF screening; leaves open prospective validation before clinical adoption.
BACKGROUND: Most patients who have heart failure with a reduced ejection fraction, when left ventricular ejection fraction (LVEF) is 40% or lower, are diagnosed in hospital. This is despite previous presentations to primary care with symptoms. We aimed to test an artificial intelligence (AI) algorithm applied to a single-lead ECG, recorded during ECG-enabled stethoscope examination, to validate a potential point-of-care screening tool for LVEF of 40% or lower. METHODS: We conducted an observational, prospective, multicentre study of a convolutional neural network (known as AI-ECG) that was previously validated for the detection of reduced LVEF using 12-lead ECG as input. We used AI-ECG retrained to interpret single-lead ECG input alone. Patients (aged ≥18 years) attending for transthoracic echocardiogram in London (UK) were recruited. All participants had 15 s of supine, single-lead ECG recorded at the four standard anatomical positions for cardiac auscultation, plus one handheld position, using an ECG-enabled stethoscope. Transthoracic echocardiogram-derived percentage LVEF was used as ground truth. The primary outcome was performance of AI-ECG at classifying reduced LVEF (LVEF ≤40%), measured using metrics including the area under the receiver operating characteristic curve (AUROC), sensitivity, and specificity, with two-sided 95% CIs. The primary outcome was reported for each position individually and with an optimal combination of AI-ECG outputs (interval range 0-1) from two positions using a rule-based approach and several classification models. This study is registered with ClinicalTrials.gov, NCT04601415. FINDINGS: Between Feb 6 and May 27, 2021, we recruited 1050 patients (mean age 62 years [SD 17·4], 535 [51%] male, 432 [41%] non-White). 945 (90%) had an ejection fraction of at least 40%, and 105 (10%) had an ejection fraction of 40% or lower. Across all positions, ECGs were most frequently of adequate quality for AI-ECG interpretation at the pulmonary position (979 [93·3%] of 1050). Quality was lowest for the aortic position (846 [80·6%]). AI-ECG performed best at the pulmonary valve position (p=0·02), with an AUROC of 0·85 (95% CI 0·81-0·89), sensitivity of 84·8% (76·2-91·3), and specificity of 69·5% (66·4-72·6). Diagnostic odds ratios did not differ by age, sex, or non-White ethnicity. Taking the optimal combination of two positions (pulmonary and handheld positions), the rule-based approach resulted in an AUROC of 0·85 (0·81-0·89), sensitivity of 82·7% (72·7-90·2), and specificity of 79·9% (77·0-82·6). Using AI-ECG outputs from these two positions, a weighted logistic regression with l2 regularisation resulted in an AUROC of 0·91 (0·88-0·95), sensitivity of 91·9% (78·1-98·3), and specificity of 80·2% (75·5-84·3). INTERPRETATION: A deep learning system applied to single-lead ECGs acquired during a routine examination with an ECG-enabled stethoscope can detect LVEF of 40% or lower. These findings highlight the potential for inexpensive, non-invasive, workflow-adapted, point-of-care screening, for earlier diagnosis and prognostically beneficial treatment.
No takes yet. Share an insight, caveat, or question.
A 2022 study conducted an observational in Heart failure with reduced ejection fraction (LVEF ≤40%) (n=1,050). AI-ECG convolutional neural network applied to 15-second single-lead ECG recorded via ECG-enabled stethoscope vs. 2D transthoracic echocardiogram-derived percentage LVEF (ground truth reference standard) was evaluated on Performance of AI-ECG at classifying reduced LVEF (LVEF ≤40%) at the single-best position (pulmonary valve) (AUROC 0.85, 95% CI 0.81-0.89, p=0.02). Single-lead AI-ECG recorded via stethoscope over the pulmonary valve detected LVEF ≤40% with an AUROC of 0.85, 84.8% sensitivity, and 69.5% specificity.
Synapse has enriched 10 related papers. Consider them for comparative context: